Use Elan Corporation plc management performance together with your portfolio to enhance returns of your portfolios and to determine Stock optimization strategy that fits your criteria.
Elan Management Effectiveness
The company has Return on Asset of 5.14 % which means that on every $1 spent on asset it made $5.14 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 102.84 % implying that it generated $102.84 on every dollar invested.
Elan Profit Margins
The company has Net Profit Margin of 35.77 % which may imply that it executes well on its competitive polices and has a good control over its expenditures and variable costs. This is very large. In the same way, it shows Net Operating Margin of 11.56 % which entails that for every dolor of revenue it generated 0.12 of operating income.
Elan Corporation plc is rated # 4 in number of employees category among related companies. The total workforce of Drug Delivery industry is currently estimated at about 24,221. Elan claims roughly 412 in number of employees contributing just under 2% to equities under Drug Delivery industry.
Executive VP of Strategic HR and Member of the Office of the CEO
Ms. Kathleen Martorano is Executive Vice President Strategic Human Resources of Elan CorporationPlc. Ms. Martorano was appointed executive vice president, strategic human resources, and a member of the office of the CEO,...
Elan employes about 412 people. The company is managed by 25 executives with total tenure of roughly 72 years, averanging almost 2.0 years of service per executive having 16.0 employee per reported executive.
Return on Elan Manpower
Revenue Per Employee
3.1 M
Revenue Per Executive
51.6 M
Net Income Per Employee
1.4 M
Net Income Per Executive
22.3 M
Working Capital Per Employee
586.7 K
Working Capital Per Executive
9.7 M
Elan Earnings Per Share
According to company disclosure Elan Corporation plc has Earnings Per Share of 0.78 times. This is 26.42% lower than that of Healthcare sector, and 50.0% higher than that of Drug Delivery industry, The Earnings Per Share for all stocks is 47.3% higher than the company.
Earnings per Share is one of the most important measures of current share price of a firm, and is used by investors to determine company overall profitability especially when it is compared to EPS of similar companies.
USA 
Equity Search
Advanced Search
Market Screener
Adviser Directory
Suggest Portfolio
Backtest Watchlist
Analyze Correlations
View Transactions
Check Volatility
Import Equities
Summary
Fundamentals
Technicals
Performance
Valuation
Volatility
History
News
Management
Discussion
